{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:10:47Z","timestamp":1789531847406,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.mayocp.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T15:26:52Z","timestamp":1669994812000},"page":"136-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Erythromelalgia: A Review of Medical Management Options and Our Approach to Management"],"prefix":"10.1016","volume":"98","author":[{"given":"Janice E.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnee U.J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Sartori-Valinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thom W.","family":"Rooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sandroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archderm.136.3.330","article-title":"Natural history of erythromelalgia: presentation and outcome in 168 patients","volume":"136","author":"Davis","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J\u00a0Med Genet"},{"issue":"21","key":"10.1016\/j.mayocp.2022.08.005_bib3","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.0602813103","article-title":"A\u00a0single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons","volume":"103","author":"Rush","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"pt 4","key":"10.1016\/j.mayocp.2022.08.005_bib4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/brain\/aww007","article-title":"Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile","volume":"139","author":"McDonnell","year":"2016","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.mayocp.2022.08.005_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molmed.2005.10.004","article-title":"Erythermalgia: molecular basis for an inherited pain syndrome","volume":"11","author":"Waxman","year":"2005","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2005.06441.x","article-title":"Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia","volume":"153","author":"Burns","year":"2005","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.08.005_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archderm.139.10.1337","article-title":"Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia","volume":"139","author":"Davis","year":"2003","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pain.2004.03.030","article-title":"Pain in primary erythromelalgia\u2014a neuropathic component?","volume":"110","author":"\u00d8rstavik","year":"2004","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.mayocp.2022.08.005_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamadermatol.2016.4404","article-title":"Epidermal nerve fiber quantification in patients with erythromelalgia","volume":"153","author":"Mantyh","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.mayocp.2022.08.005_bib10","series-title":"Treatment of Skin Disease: Comprehensive Therapeutic Strategies","article-title":"Erythromelalgia","author":"Mork","year":"2022"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.138.1.17","article-title":"Lidocaine patch for pain of erythromelalgia","volume":"138","author":"Davis","year":"2002","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.08.005_bib12","first-page":"1320","article-title":"Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients","volume":"141","author":"Davis","year":"2005","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archderm.142.3.283","article-title":"Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option?","volume":"142","author":"Sandroni","year":"2006","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib14","first-page":"308","article-title":"Topical amitriptyline combined with ketamine for the treatment of erythromelalgia: a retrospective study of 36 patients at Mayo Clinic","volume":"12","author":"Poterucha","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"829","key":"10.1016\/j.mayocp.2022.08.005_bib17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/pgmj.70.829.841","article-title":"The use of capsaicin cream in a case of erythromelalgia","volume":"70","author":"Muhiddin","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.mayocp.2022.08.005_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1067\/mjd.2000.109301","article-title":"Erythromelalgia: new theories and new therapies","author":"Cohen","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mayocp.2022.08.005_bib19","first-page":"973","article-title":"Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation","volume":"10","author":"Low","year":"2017","journal-title":"J\u00a0Pain Res"},{"issue":"9","key":"10.1016\/j.mayocp.2022.08.005_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2015.0511","article-title":"Topically applied midodrine, 0.2%, an \u03b11-agonist, for the treatment of erythromelalgia","volume":"151","author":"Davis","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/10428194.2016.1205740","article-title":"Erythromelalgia in patients with essential thrombocythemia and polycythemia vera","volume":"58","author":"Hou","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0002-9343(91)90160-Y","article-title":"Erythromelalgia: review of clinical characteristics and pathophysiology","volume":"91","author":"Kurzrock","year":"1991","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0190-9622(08)80053-9","article-title":"Treatment of primary erythromelalgia with piroxicam","volume":"24","author":"Calderone","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2016.08.048","article-title":"Erythromelalgia: identification of a corticosteroid-responsive subset","volume":"76","author":"Pagani-Estevez","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"19","key":"10.1016\/j.mayocp.2022.08.005_bib25","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1111\/bph.12788","article-title":"Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels","volume":"171","author":"Cregg","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0256-4947.55316","article-title":"Experience with oral mexiletine in primary erythromelalgia in children","volume":"29","author":"Iqbal","year":"2009","journal-title":"Ann Saudi Med"},{"issue":"6","key":"10.1016\/j.mayocp.2022.08.005_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamaneurol.2016.0389","article-title":"Pharmacotherapy for pain in a family with inherited erythromelalgia guided by genomic analysis and functional profiling","volume":"73","author":"Geha","year":"2016","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/mus.23968","article-title":"An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder","volume":"49","author":"Meijer","year":"2014","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.mayocp.2022.08.005_bib29","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1212\/NXG.0000000000000570","article-title":"Erythromelalgia: a child with V400M mutation in the SCN9A gene","volume":"7","author":"Nwebube","year":"2021","journal-title":"Neurol Genet"},{"issue":"12","key":"10.1016\/j.mayocp.2022.08.005_bib30","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/bph.13935","article-title":"Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav 1.7 mutation I234T","volume":"175","author":"Yang","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pain.2011.09.008","article-title":"Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker","volume":"153","author":"Goldberg","year":"2012","journal-title":"Pain"},{"issue":"335","key":"10.1016\/j.mayocp.2022.08.005_bib32","doi-asserted-by":"crossref","first-page":"335ra56","DOI":"10.1126\/scitranslmed.aad7653","article-title":"Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia","volume":"8","author":"Cao","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.mayocp.2022.08.005_bib33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.135.12.1447","article-title":"Lidocaine and mexiletine therapy for erythromelalgia","volume":"135","author":"Kuhnert","year":"1999","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib34","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1542\/peds.2004-1395","article-title":"Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment","volume":"115","author":"Nathan","year":"2005","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.mayocp.2022.08.005_bib35","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/phar.2189","article-title":"Intravenous lidocaine for acute pain: a systematic review","volume":"38","author":"Masic","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.mayocp.2022.08.005_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12887-015-0515-4","article-title":"Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study","volume":"15","author":"Sheehy","year":"2015","journal-title":"BMC Pediatr"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib37","doi-asserted-by":"crossref","first-page":"e01582","DOI":"10.1213\/XAA.0000000000001582","article-title":"Intravenous ketamine infusion as an adjunctive pain treatment for erythromelalgia: a pediatric case report","volume":"16","author":"Montoya","year":"2022","journal-title":"A\u00a0A Pract"},{"issue":"7","key":"10.1016\/j.mayocp.2022.08.005_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/0883073811427784","article-title":"Secondary erythromelalgia successfully treated with intravenous immunoglobulin","volume":"27","author":"Moody","year":"2012","journal-title":"J\u00a0Child Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MAJ.0b013e31812f65e7","article-title":"A\u00a0patient with adult erythermalgia: evidence suggesting an autoimmune etiology","volume":"335","author":"Jackson","year":"2008","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2022.08.005_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2133.2002.4653_6.x","article-title":"Treatment of erythromelalgia with a serotonin\/noradrenaline reuptake inhibitor","volume":"146","author":"Moiin","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/rheumatology\/keg137","article-title":"Serotonin reuptake inhibitors, Raynaud's phenomenon and erythromelalgia","volume":"42","author":"Rey","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mayocp.2022.08.005_bib42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1212\/WNL.43.3_Part_1.621","article-title":"Erythromelalgia: association with hereditary sensory neuropathy and response to amitriptyline","author":"Herskovitz","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib44","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/00000542-199704000-00029","article-title":"Erythromelalgia pain managed with gabapentin","volume":"86","author":"McGraw","year":"1997","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib46","first-page":"12","article-title":"Pregabalin induced syndrome of inappropriate anti-diuretic hormone (SIADH) secretion: a case report","volume":"10","author":"Metwali","year":"2019","journal-title":"J\u00a0Basic Clin Pharm"},{"issue":"5","key":"10.1016\/j.mayocp.2022.08.005_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/RHU.0b013e31829cf8a2","article-title":"Response of primary erythromelalgia to pregabalin therapy","volume":"19","author":"Kalava","year":"2013","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib48","first-page":"CS1","article-title":"Managing late onset primary erythromelalgia with oral pregabalin","volume":"5","author":"Poddar","year":"2017","journal-title":"Int J Rheumatol Clin Immunol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.08.005_bib49","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/00015550310015031","article-title":"Prostacyclin reduces symptoms and sympathetic dysfunction in erythromelalgia in a double-blind randomized pilot study","volume":"83","author":"Kalgaard","year":"2003","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.08.005_bib50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.0022-202X.2004.22339.x","article-title":"The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia\u2014a double-blind, crossover, placebo-compared study","volume":"122","author":"Mork","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"issue":"7395","key":"10.1016\/j.mayocp.2022.08.005_bib51","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/bmj.326.7395.910","article-title":"Erythromelalgia induced by possible calcium channel blockade by ciclosporin","volume":"326","author":"Thami","year":"2003","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.mayocp.2022.08.005_bib52","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/106002809603000510","article-title":"Possible erythromelalgia-like syndrome associated with nifedipine in a patient with Raynaud's phenomenon","volume":"30","author":"Sunahara","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.mayocp.2022.08.005_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1345\/aph.1A186","article-title":"High-dose oral magnesium treatment of chronic, intractable erythromelalgia","volume":"36","author":"Cohen","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.mayocp.2022.08.005_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1752-1947-8-69","article-title":"An Egyptian child with erythromelalgia responding to a new line of treatment: a case report and review of the literature","volume":"8","author":"Al-Minshawy","year":"2014","journal-title":"J\u00a0Med Case Rep"},{"issue":"1-2","key":"10.1016\/j.mayocp.2022.08.005_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-1838(95)00121-2","article-title":"Treatment of primary erythromelalgia with cyproheptadine","volume":"58","author":"Sakakibara","year":"1996","journal-title":"J\u00a0Auton Nerv Syst"},{"issue":"11-12","key":"10.1016\/j.mayocp.2022.08.005_bib56","first-page":"777","article-title":"[Familial erythermalgia treated with pizotifen]","volume":"122","author":"Guillet","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.mayocp.2022.08.005_bib57","doi-asserted-by":"crossref","unstructured":"Giaimo JD, Paulk KL, Phelan HA, Lau FH, Grieshaber EB, Carter JE. Remission of pain from frostbite and erythromelalgia with epidural infusion of ropivacaine: results of a two-year follow-up. Am Surg. Published online December 14, 2020. https:\/\/doi.org\/10.1177\/0003134820956923","DOI":"10.1177\/0003134820956923"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib58","first-page":"142","article-title":"Continuous epidural infusion of bupivacaine and fentanyl for erythromelalgia in an adolescent","volume":"74","author":"D'Angelo","year":"1992","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.mayocp.2022.08.005_bib59","first-page":"371","article-title":"[Cervical epidural infusion of morphine and bupivacaine in severe erythromelalgia]","volume":"29","author":"Mohr","year":"1994","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"5","key":"10.1016\/j.mayocp.2022.08.005_bib60","first-page":"1097","article-title":"Refractory idiopathic erythromelalgia","volume":"82","author":"Rauck","year":"1996","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.mayocp.2022.08.005_bib61","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/rapm.2001.25930","article-title":"Resolution of refractory symptoms of secondary erythermalgia with intermittent epidural bupivacaine","volume":"26","author":"Stricker","year":"2001","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib62","first-page":"91","article-title":"Case report and literature review: interventional management of erythromelalgia","volume":"6","author":"Chinn","year":"2019","journal-title":"Transl Perioper Pain Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.08.005_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/adc.88.1.65","article-title":"The use of regional anaesthetic blockade in a child with recurrent erythromelalgia","volume":"88","author":"Harrison","year":"2003","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib64","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jdcr.2019.01.029","article-title":"Pediatric erythromelalgia treated with epidural ropivacaine infusion","volume":"5","author":"Lee","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2022.08.005_bib65","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3892\/etm.2016.3088","article-title":"Secondary erythromelalgia successfully treated with patient-controlled epidural analgesia and interferon \u03b1-2b: a case report and review of the literature","volume":"11","author":"Li","year":"2016","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.08.005_bib66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1365-2133.2000.03795.x","article-title":"A\u00a0refractory case of secondary erythermalgia successfully treated with lumbar sympathetic ganglion block","volume":"143","author":"Seishima","year":"2000","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.08.005_bib67","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jvs.2018.05.226","article-title":"Chemical lumbar sympathectomy in the treatment of recalcitrant erythromelalgia","volume":"68","author":"Wang","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2022.08.005_bib68","first-page":"763","article-title":"Long-term remission of primary erythermalgia with R1150W polymorphism in SCN9A after chemical lumbar sympathectomy","volume":"20","author":"Zhang","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.mayocp.2022.08.005_bib69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1752-1947-3-106","article-title":"Late-onset erythromelalgia in a previously healthy young woman: a case report and review of the literature","volume":"3","author":"Gaur","year":"2009","journal-title":"J\u00a0Med Case Rep"},{"issue":"12","key":"10.1016\/j.mayocp.2022.08.005_bib70","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archdermatol.2008.515","article-title":"Intervention for erythromelalgia, a chronic pain syndrome: comprehensive pain rehabilitation center, Mayo Clinic","volume":"144","author":"Durosaro","year":"2008","journal-title":"Arch Dermatol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622004980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622004980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:40:17Z","timestamp":1758418817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622004980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0025619622004980"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.08.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythromelalgia: A Review of Medical Management Options and Our Approach to Management","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}